Search Within

Martin Stuart Tallman

  1. "2018"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (29)
  3. Book Section (2)
Groups
  1. Adult Leukemia (63)
  2. Center for Hematologic Malignancies (63)
  3. Department of Medicine (63)
  4. Hematologic Malignancies, Division of (63)
  5. Weinberg Fellows (19)
  6. GSK Faculty (15)

More Groups

People
  1. Eytan Stein (14)
  2. Ross Levine (11)
  3. Aaron Goldberg (9)
  4. Christopher Famulare (9)
  5. Jae Park (9)
  6. Sean Devlin (8)

More People

Years
  1. 2018 (63)
Publications
  1. Blood (31)
  2. Blood Advances (5)
  3. Leukemia Research (4)
  4. Biology of Blood and Marrow Transplantation (3)
  5. American Journal of Hematology (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Hematology (36)
  2. Elsevier Inc. (4)
  3. Elsevier Ltd (4)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (63)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study
    Meeting Abstract

    Pollyea, D. A.; Dinardo, C. D.; de Botton, S.; Stein, E.; Roboz, G. J.; Mims, A. S.; Swords, R. T.; Altman, J. K.; Collins, R.; Mannis, G. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • First-line therapy for acute promyelocytic leukemia: Chemotherapy-based approach
    Book Section

    Goldberg, A. D.; Tallman, M. S.
    In Abla, O.; Lo Coco, F.; Sanz, M. A. (Eds.) Acute Promyelocytic Leukemia: A Clinical Guide (2018)

    Fulltext@MSK | Save
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Slit-Robo pathway is clinically relevant and may represent a potential target in acute promyelocytic leukemia
    Meeting Abstract

    Weinhauser, I.; Pereira-Martins, D. A.; Ortiz, C.; Schiavinato, J. L.; Bonaldo, C.; Koury, L. C.; Wagatsuma, V. M. D.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
    Meeting Abstract

    Talati, C.; Goldberg, A. D.; Przespolewski, A.; Chan, O.; Al Ali, N.; Famulare, C.; Sallman, D. A.; Padron, E.; Kuykendall, A.; List, A. F.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Hematologic malignancies arising in patients with germ cell tumors: Secondary somatic differentiation of hematopoietic malignancies from germ cell precursors
    Meeting Abstract

    Taylor, J.; Donoghue, M.; Rampal, R. K.; Tamari, R.; Tallman, M. S.; Feldman, D. R.; Taylor, B. S.; Abdel-Wahab, O. I.
    Blood (2018)

    Fulltext@MSK | Save
  • Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents
    Meeting Abstract

    Taylor, J.; Coleman, M.; Alvarez, K.; Pichardo, J.; Sen, F.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; Tallman, M. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Ratify (Alliance 10603): Prognostic impact of FLT3 tyrosine kinase domain (TKD) and NPM1 mutation status in patients with newly diagnosed acute myeloid leukemia (AML) treated with midostaurin or placebo plus standard chemotherapy
    Meeting Abstract

    Voso, M. T.; Larson, R. A.; Prior, T.; Marcucci, G.; Jones, D.; Krauter, J.; Heuser, M.; Lavorgna, S.; Nomdedeu, J.; Geyer, S. M.; more...
    Blood (2018)

    Fulltext@MSK | Save